Tower Research Capital (TRC)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,398
Closed -$43K 6665
2022
Q4
$43K Buy
7,398
+5,351
+261% +$31.1K ﹤0.01% 2480
2022
Q3
$14K Sell
2,047
-27,165
-93% -$186K ﹤0.01% 4246
2022
Q2
$123K Buy
29,212
+4,205
+17% +$17.7K ﹤0.01% 2131
2022
Q1
$84K Buy
25,007
+11,316
+83% +$38K ﹤0.01% 2348
2021
Q4
$44K Buy
13,691
+10,366
+312% +$33.3K ﹤0.01% 2871
2021
Q3
$11K Sell
3,325
-2,975
-47% -$9.84K ﹤0.01% 4281
2021
Q2
$27K Sell
6,300
-4,391
-41% -$18.8K ﹤0.01% 3621
2021
Q1
$53K Buy
10,691
+5,224
+96% +$25.9K ﹤0.01% 3080
2020
Q4
$69K Sell
5,467
-24,751
-82% -$312K ﹤0.01% 2744
2020
Q3
$297K Buy
30,218
+25,104
+491% +$247K ﹤0.01% 2201
2020
Q2
$51K Buy
+5,114
New +$51K ﹤0.01% 3037
2020
Q1
Sell
-409
Closed -$4K 4190
2019
Q4
$4K Sell
409
-272
-40% -$2.66K ﹤0.01% 2842
2019
Q3
$4K Buy
+681
New +$4K ﹤0.01% 3487
2019
Q2
Sell
-288
Closed -$3K 4509
2019
Q1
$3K Sell
288
-635
-69% -$6.62K ﹤0.01% 3340
2018
Q4
$12K Buy
+923
New +$12K ﹤0.01% 2350
2018
Q3
Sell
-4,537
Closed -$76K 4393
2018
Q2
$76K Buy
+4,537
New +$76K ﹤0.01% 1610
2017
Q4
Sell
-3,456
Closed -$51K 4291
2017
Q3
$51K Buy
+3,456
New +$51K ﹤0.01% 1965
2017
Q1
Sell
-3,998
Closed -$41K 4161
2016
Q4
$41K Buy
+3,998
New +$41K ﹤0.01% 1562
2016
Q1
Sell
-456
Closed -$9K 5183
2015
Q4
$9K Buy
+456
New +$9K ﹤0.01% 2318
2014
Q3
Sell
-3,169
Closed -$32K 5037
2014
Q2
$32K Buy
3,169
+1,503
+90% +$15.2K ﹤0.01% 1567
2014
Q1
$22K Buy
+1,666
New +$22K ﹤0.01% 1800